European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 483-488 , May 2010

Prognosis of extremity osteosarcoma in patients aged 40–60 years: A cohort/case controlled study at a single institute

  • W.S. Song

      Affiliations

    • Department of Orthopedic Surgery, Korea Cancer Center Hospital, 215-4, Gongneung-dong, Nowon-gu, Seoul 139-706, Republic of Korea
    • ,
  • C.-B. Kong

      Affiliations

    • Department of Orthopedic Surgery, Korea Cancer Center Hospital, 215-4, Gongneung-dong, Nowon-gu, Seoul 139-706, Republic of Korea
    • ,
  • D.-G. Jeon

      Affiliations

    • Department of Orthopedic Surgery, Korea Cancer Center Hospital, 215-4, Gongneung-dong, Nowon-gu, Seoul 139-706, Republic of Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 970 1242; fax: +82 2 970 2403.
    • ,
  • W.H. Cho

      Affiliations

    • Department of Orthopedic Surgery, Korea Cancer Center Hospital, 215-4, Gongneung-dong, Nowon-gu, Seoul 139-706, Republic of Korea
    • ,
  • M.S. Kim

      Affiliations

    • Department of Pathology, Korea Cancer Center Hospital, Seoul, Republic of Korea
    • ,
  • J.A. Lee

      Affiliations

    • Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Republic of Korea
    • ,
  • J.Y. Yoo

      Affiliations

    • Department of Radiology, Korea Cancer Center Hospital, Seoul, Republic of Korea
    • ,
  • J.D. Kim

      Affiliations

    • Department of Orthopedic Surgery, Kosin University Medical School, Pusan, Republic of Korea
    • ,
  • S.-Y. Lee

      Affiliations

    • Department of Orthopedic Surgery, Korea Cancer Center Hospital, 215-4, Gongneung-dong, Nowon-gu, Seoul 139-706, Republic of Korea

,Accepted 15 March 2010.

References 

  1. Bielack SS, Kempf-Bielack B, Heise U, Schwenzer D, Winkler K. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German–Austrian–Swiss Osteosarcoma Study Group. J Clin Oncol. 1999;17:1164
  2. Shaylor PJ, Peake D, Grimer RJ, Carter SR, Tillman RM, Spooner D. Paget's osteosarcoma – no cure in sight. Sarcoma. 1999;3:191–192
  3. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776–790
  4. Carsi B, Rock MG. Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res. 2002;397:53–61
  5. Huvos AG, Butler A, Bretsky SS. Osteogenic sarcoma associated with Paget's disease of bone. A clinicopathologic study of 65 patients. Cancer. 1983;52:1489–1495
  6. Nishida Y, Isu K, Ueda T, et al. Osteosarcoma in the elderly over 60 years: a multicenter study by the Japanese Musculoskeletal Oncology Group. J Surg Oncol. 2009;100:48–54
  7. Bacci G, Ferrari S, Mercuri M, et al. Neoadjuvant chemotherapy for osteosarcoma of the extremities in patients aged 41–60 years: outcome in 34 cases treated with adriamycin, cisplatinum and ifosfamide between 1984 and 1999. Acta Orthop. 2007;78:377–384
  8. Grimer RJ, Cannon SR, Taminiau AM, et al. Osteosarcoma over the age of forty. Eur J Cancer. 2003;39:157–163
  9. Manoso MW, Healey JH, Boland PJ, et al. De novo osteogenic sarcoma in patients older than forty: benefit of multimodality therapy. Clin Orthop Relat Res. 2005;438:110–115
  10. Kim MS, Lee SY, Lee TR, et al. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol. 2009;20:955–960
  11. Paksoy M, Ipek T, Colak T, Cebeci H. Influence of age on prognosis and management of patients with colorectal carcinoma. Eur J Surg. 1999;165:55–59
  12. Smith BR, Stabile BE. Extreme aggressiveness and lethality of gastric adenocarcinoma in the very young. Arch Surg. 2009;144:506–510
  13. Xiong Q, Valero V, Kau V, et al. Female patients with breast carcinoma age 30 years and younger have a poor prognosis: the M.D. Anderson Cancer Center experience. Cancer. 2001;92:2523–2528
  14. Yantiss RK, Goodarzi M, Zhou XK, et al. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol. 2009;33:572–582
  15. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–120
  16. Rosen G, Marcove RC, Huvos AG, et al. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol. 1983;106(Suppl):55–67
  17. Bieling P, Rehan N, Winkler P, et al. Tumor size and prognosis in aggressively treated osteosarcoma. J Clin Oncol. 1996;14:848–858
  18. Longhi A, Errani C, Gonzales-Arabio D, Ferrari C, Mercuri M. Osteosarcoma in patients older than 65 years. J Clin Oncol. 2008;26:5368–5373
  19. Bacci G, Bertoni F, Longhi A, et al. Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor. Cancer. 2003;97:3068–3075
  20. Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: a critical review. J Clin Oncol. 1994;12:423–431
  21. Kim MS, Lee SY, Cho WH, et al. Initial tumor size predicts histologic response and survival in localized osteosarcoma patients. J Surg Oncol. 2008;97:456–461
  22. Ozaki T, Flege S, Kevric M, et al. Osteosarcoma of the pelvis: experience of the cooperative osteosarcoma study group. J Clin Oncol. 2003;21:334–341
  23. Hauben EI, Weeden S, Pringle J, Van Marck EA, Hogendoorn PC. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer. 2002;38:1218–1225
  24. Bacci G, Mercuri M, Longhi A, et al. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer. 2005;41:2079–2085
  25. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience. Cancer. 1992;69:698–708

PII: S0748-7983(10)00062-4

doi: 10.1016/j.ejso.2010.03.006

European Journal of Surgical Oncology
Volume 36, Issue 5 , Pages 483-488 , May 2010

Article Tools

* Image Usage & Resolution